Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging

Eric M. Robinson, Brooke E. Rosenbaum, Yilong Zhang, Robert Rogers, Jeremy Tchack, Russell S. Berman, Farbod Darvishian, Iman Osman, Richard L. Shapiro, Yongzhao Shao, David Polsky

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Background: Patients with thick primary melanomas (≥4 mm) have highly variable survival outcomes. Cell proliferation marker Ki-67 has been identified as promising biomarker in thick melanoma but has not been evaluated since the wide spread adoption of sentinel lymph node biopsy. We revisit its prognostic relevance in the sentinel node era. Methods: We studied patients with thick (≥4 mm) primary melanoma prospectively enrolled in a clinicopathological biospecimen database from 2002 to 2015, and evaluated the prognostic value of Ki-67 expression while controlling for features included in the existing staging criteria. Results: We analyzed 68 patients who underwent lymph node sampling and who had an available tumor for Ki-67 immunohistochemical (IHC) staining. The median tumor thickness was 6.0 mm; the median follow-up was 2.6 years. In multivariable analysis including nodal status and primary tumor ulceration, Ki-67 expression was an independent predictor of worse recurrence-free survival (HR 2.19, P = 0.024) and overall survival (HR 2.49, P = 0.028). Natural log-transformed tumor thickness (ln [thickness]) was also significantly associated with worse OS (HR 2.39, P = 0.010). Conclusion: We identify Ki-67 and ln (thickness) as potential biomarkers for patients with thick melanoma who have undergone nodal staging. If validated in additional studies, these biomarkers could be integrated into the staging criteria to improve risk-stratification.

Original languageEnglish
Pages (from-to)150-156
Number of pages7
JournalJournal of Surgical Oncology
Volume118
Issue number1
DOIs
StatePublished - 1 Jul 2018
Externally publishedYes

Keywords

  • Ki-67
  • T4 melanoma
  • sentinel lymph node
  • survival

Fingerprint

Dive into the research topics of 'Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging'. Together they form a unique fingerprint.

Cite this